Profile

Cover photo
Teva Pharmaceutical Industries Ltd.
687 followers|481,654 views
AboutPostsPhotosYouTube

Stream

 
For people past a certain age, adhering to treatment may be difficult - especially when taking 4 or 5 different medications per day. Unfortunately, poor treatment adherence also results in numerous hospitalizations annually. 
Teva in France has committed to better understanding the causes of poor adherence, and mobilized an extensive campaign to help raise awareness and action to improve medication adherence among the elderly. The “Marguerite” program was designed to ensure that patients and caregivers in France understand the importance of playing an active role in adhering to treatment, together with their physician and pharmacist. 
View additional information and recommendations to facilitate medication adherence (in French): http://www.teva-laboratoires.com/l-observance
1
Add a comment...
 
Happy Chinese New Year! (Xīn Nián Kuài Lè !) We wish happiness, prosperity and longevity to all who are celebrating the Year of the Goat in 2015!
2
Add a comment...
 
"Love and compassion are necessities, not luxuries. Without them humanity cannot survive." ~Dalai Lama
(true for #ValentinesDay, and every day of the year!)
2
1
Mercedes Blackaller's profile photo
Add a comment...
 
Did you know that Teva Pharmaceuticals is not only the world’s largest generic drug maker, but also a globally recognized leader in specialty medicines?  Our unique offering applies more than 110 years of experience, scientific expertise and innovation to making quality medicines accessible to people worldwide.
3
Add a comment...
 
These employees of Teva in Lithuania have good reason to be proud! The launch of a new production line, a new research facility, stable export and revenue increase, and overall successful operations are just a few of the reasons why Sicor Biotech, a member of Teva Group, was recently recognized with an award from the Lithuanian Confederation of Industrialists.  It was the fourth time Sicor Biotech has received this award, demonstrating consistently positive evaluations of production and service volumes, labor and manufacturing quality, work environment as well as many other factors that help to create and expand business overall in Lithuania.  Congratulations! 
3
Add a comment...
Have them in circles
687 people
John Michael Lani (Quorum Review)'s profile photo
Health2.0 India's profile photo
Redbird Medical's profile photo
Luke Brown's profile photo
Rohit Yerneni's profile photo
Debajyoti Basu's profile photo
Mining Market Research's profile photo
Ion Labs - Private Label and Contract Manufacturing - Dietary Supplements's profile photo
Svasam Karthik's profile photo
 
"We know that our talented, educated and motivated employees are the most powerful sources of PLIVA's success,” says Blagica Petrovac Šikić, Sr. Director of Human Resources at PLIVA in Croatia, a member of Teva group. “Our commitment is to enable each employee to acquire the knowledge necessary to perform their jobs effectively, and support learning and development throughout their career."  Congratulations to PLIVA on being named among the most desirable employers in Croatia, based on a study conducted by the MyJob portal.  
3
Add a comment...
 
And now for something completely different... (but wonderful!)
Colleagues from our Packaging Operations in Eastbourne represented Teva UK Limited in the annual Pancake Race to aid St Wilfrid's Hospice (a close neighbor to the Teva facility).
Participants ran the course while flipping pancakes, as spectators enthusiastically cheered on the teams. Congratulations to all of the runners and the supportive crowd at the event and, more importantly, thanks to everyone who helped raise funds for this very worthy cause.
3
Add a comment...
 
2014 was an excellent year for the Teva Generics team, making many more affordable, high quality medicines available to patients worldwide.  
"In 2014, our generic business launched 19 products in the US, 209 in Europe and 87 in the rest of the world. Teva is in a very strong and unique position not only in Europe but also internationally, being among the top three generic companies in 30 markets around the world...  We have an amazing pipeline and we work closely with our manufacturing network to select the right portfolio, getting medicines to market faster."  
~Siggi Olafsson, President and CEO, Teva Global Generic Medicines  
2
Add a comment...
 
Teva Reports Fourth Quarter and Full Year 2014 Results
“In order to take a great leap forward you must first create a solid foundation from which to drive sustainable profitable growth. 2014 was that year for Teva," stated Erez Vigodman, CEO of Teva. Read all of the details on our website: http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-newsArticle&ID=2013904
TEVA Investor Relations - Teva Reports Fourth Quarter and Full Year 2014 Results
1
Add a comment...
 
Jerusalem is a dynamic city, with a diverse and talented life sciences community that includes a unique mix of academia, industry, biotech, healthcare and more. Teva is thrilled to be part of this energetic community and a member of BIOJERUSALEM, an initiative of the Jerusalem Development Authority, that brings together an innovative network of people and resources to expand the economy and sustainable enterprise of this modern, ancient city. A group of Teva managers were warmly received at a recent Bios4Bios session in Jerusalem where they shared insights and innovations in the local market.
1
Add a comment...
 
A new Teva R&D extension for the development of complex molecules and new therapeutic entities was officially opened last month at PLIVA in Croatia. “Our employees in Croatia know they are not just part of a local operation, they are at the heart of something much bigger,” said Dr. Michael Hayden, President of Teva’s Global R&D and Chief Scientific Officer.  “They are driving highly complex projects, requiring intimate knowledge of international regulatory requirements and working hand-in-hand with a truly global team. This enables Teva to meet the needs of our patients worldwide.”  Among esteemed guests at the opening ceremony was the President of the Republic of Croatia, Dr. Ivo Josipović, together with members of the Croatian professional and scientific communities.  
2
Add a comment...
Story
Tagline
We make quality healthcare accessible around the world.
Introduction

This is the official Google+ page for Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. 

Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. 

Teva currently employs approximately 47,000 people around the world and reached $16.1 billion in net sales in 2010.

Note to Users: This page is intended to provide news and updates about our company, and Teva reserves the right to delete any comments that it considers to be inappropriate, abusive or spam. 

Adverse events for any of our products should be reported to: Safety.AE@teva.co.il 

Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details may be found here: http://www.tevapharm.com/en-US/Pages/Contact-Us.aspx